Metabolites
Displaying compounds 2001 - 2025 of 16042 in total
| YMDB ID | Name CAS Number | IUPAC Name | Formula Weight | Structure |
|---|---|---|---|---|
| YMDB12703 | DG(10:0/26:0/0:0) | (2R)-1-(decanoyloxy)-3-hydroxypropan-2-yl hexacosanoate | C39H76O5 625.032 | |
| YMDB12727 | DG(12:0/24:0/0:0) | (2R)-1-(dodecanoyloxy)-3-hydroxypropan-2-yl tetracosanoate | C39H76O5 625.032 | |
| YMDB13002 | DG(18:0/18:0/0:0) | (2R)-1-hydroxy-3-(octadecanoyloxy)propan-2-yl octadecanoate | C39H76O5 625.032 | |
| YMDB12750 | DG(14:0/22:0/0:0) | (2R)-1-hydroxy-3-(tetradecanoyloxy)propan-2-yl docosanoate | C39H76O5 625.032 | |
| YMDB16121 | CE(16:0) | (1S,2R,5S,10S,11S,14R,15R)-2,15-dimethyl-14-[(2R)-6-methylheptan-2-yl]tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-en-5-yl hexadecanoate | C43H76O2 625.0623 | |
| YMDB01772 | Petunidin 3-O-(coumaroylglucoside) | 2-(3,4-dihydroxy-5-methoxyphenyl)-5,7-dihydroxy-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2E)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy}methyl)oxan-2-yl]oxy}-1λ⁴-chromen-1-ylium | C31H29O14 625.5536 | |
| YMDB01104 | Cer 18:0;3/20:0;1 | (9R)-9-hydroxy-N-[(2S,3S,4R)-1,3,4-trihydroxyoctadecan-2-yl]icosanamide | C38H77NO5 628.0217 | |
| YMDB01482 | D-Glycero-D-manno-heptose 1961-73-5 | 2,3,4,5,6,7-hexahydroxyheptanal; 5-(1,2,3-trihydroxypropyl)oxolane-2,3,4-triol; 6-(1,2-dihydroxyethyl)oxane-2,3,4,5-tetrol | C21H42O21 630.5456 | |
| YMDB13464 | PA(15:1(9Z)/16:1(9Z)) | [(2R)-2-[(9Z)-hexadec-9-enoyloxy]-3-[(9Z)-pentadec-9-enoyloxy]propoxy]phosphonic acid | C34H63O8P 630.844 | |
| YMDB13465 | PA(15:1(9Z)/16:1(11Z)) | [(2R)-2-[(11Z)-hexadec-11-enoyloxy]-3-[(9Z)-pentadec-9-enoyloxy]propoxy]phosphonic acid | C34H63O8P 630.844 | |
| YMDB13466 | PA(15:1(11Z)/16:1(9Z)) | [(2R)-2-[(9Z)-hexadec-9-enoyloxy]-3-[(11Z)-pentadec-11-enoyloxy]propoxy]phosphonic acid | C34H63O8P 630.844 | |
| YMDB13467 | PA(15:1(11Z)/16:1(11Z)) | [(2R)-2-[(11Z)-hexadec-11-enoyloxy]-3-[(11Z)-pentadec-11-enoyloxy]propoxy]phosphonic acid | C34H63O8P 630.844 | |
| YMDB14050 | PE(14:1(9Z)/14:1(9Z)) | (2-aminoethoxy)[(2R)-2,3-bis[(9Z)-tetradec-9-enoyloxy]propoxy]phosphinic acid | C33H62NO8P 631.821 | |
| YMDB14051 | PE(14:1(9Z)/14:1(11Z)) | (2-aminoethoxy)[(2R)-2-[(11Z)-tetradec-11-enoyloxy]-3-[(9Z)-tetradec-9-enoyloxy]propoxy]phosphinic acid | C33H62NO8P 631.832 | |
| YMDB14052 | PE(14:1(11Z)/14:1(9Z)) | (2-aminoethoxy)[(2R)-3-[(11Z)-tetradec-11-enoyloxy]-2-[(9Z)-tetradec-9-enoyloxy]propoxy]phosphinic acid | C33H62NO8P 631.832 | |
| YMDB14053 | PE(14:1(11Z)/14:1(11Z)) | (2-aminoethoxy)[(2R)-2,3-bis[(11Z)-tetradec-11-enoyloxy]propoxy]phosphinic acid | C33H62NO8P 631.832 | |
| YMDB13469 | PA(15:0/16:1(9Z)) | [(2R)-2-[(9Z)-hexadec-9-enoyloxy]-3-(pentadecanoyloxy)propoxy]phosphonic acid | C34H65O8P 632.86 | |
| YMDB13470 | PA(15:0/16:1(11Z)) | [(2R)-2-[(11Z)-hexadec-11-enoyloxy]-3-(pentadecanoyloxy)propoxy]phosphonic acid | C34H65O8P 632.86 | |
| YMDB13471 | PA(15:1(9Z)/16:0) | [(2R)-2-(hexadecanoyloxy)-3-[(9Z)-pentadec-9-enoyloxy]propoxy]phosphonic acid | C34H65O8P 632.86 | |
| YMDB13472 | PA(15:1(11Z)/16:0) | [(2R)-2-(hexadecanoyloxy)-3-[(11Z)-pentadec-11-enoyloxy]propoxy]phosphonic acid | C34H65O8P 632.86 | |
| YMDB00551 | ergosteryl palmitoleate | (1S,2R,5S,11R,14R,15R)-14-[(2R,3E,5R)-5,6-dimethylhept-3-en-2-yl]-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadeca-7,9-dien-5-yl (9Z)-hexadec-9-enoate | C44H72O2 633.0413 | |
| YMDB13703 | PE-NMe2(12:0/14:1(9Z)) | [2-(dimethylamino)ethoxy][3-(dodecanoyloxy)-2-[(9Z)-tetradec-9-enoyloxy]propoxy]phosphinic acid | C33H64NO8P 633.848 | |
| YMDB13704 | PE-NMe2(12:0/14:1(11Z)) | [2-(dimethylamino)ethoxy][3-(dodecanoyloxy)-2-[(11Z)-tetradec-11-enoyloxy]propoxy]phosphinic acid | C33H64NO8P 633.848 | |
| YMDB13714 | PE-NMe2(10:0/16:1(9Z)) | [3-(decanoyloxy)-2-[(9Z)-hexadec-9-enoyloxy]propoxy][2-(dimethylamino)ethoxy]phosphinic acid | C33H64NO8P 633.848 | |
| YMDB13715 | PE-NMe2(10:0/16:1(11Z)) | [3-(decanoyloxy)-2-[(11Z)-hexadec-11-enoyloxy]propoxy][2-(dimethylamino)ethoxy]phosphinic acid | C33H64NO8P 633.848 |